Earlier this year, Generika announced plans to expand its franchising operations nationwide, particularly to key cities in Visayas and Mindanao, as well as untapped areas of Luzon to augment its strong presence in Metro Manila and nearby provinces.
In line with this plan of accelerating the number of new franchise stores, the company has rolled out affordable investment packages – Satellite, Drugstore Conversion and Small Town – that significantly reduce the capital requirements for opening a Generika outlet.
The Satellite package is offered to Generika franchisees who would like to have one more branch near his/her main outlet. The Drugstore Conversion package applies to existing pharmacies that wish to convert to a Generika Drugstore, while the Small Town package is recommended for Generika outlets to be located in a rural area with a population of less than 50,000.
For all the franchise packages, Generika provides marketing and operations assistance to help new stores in their promotional efforts and revenue-enhancing efforts, especially in areas where Generika is just starting to thrive.
Starting out with a single outlet in Alabang in 2004, Generika Drugstore expanded to 16 company-owned stores in 2008. Since then, Generika opened up franchising opportunities to Filipino entrepreneurs. With 210 branches nationwide, Generika plans to add at least 180 stores annually.
Compared to other generics outlets, Generika Drugstore is distinguished by its air-conditioned stores that protect the therapeutic value of its medicines while ensuring customer comfort and convenience. Store personnel are well-trained to offer patient counseling and other value-added services.
To explore the Generika franchise business, interested entrepreneurs may contact the Generika Franchising Services Corp (GFSC) at 824.4685 or 0922.898.4982. You may also visit the company website at www.generika.com.ph. A dedicated team of Generika Business Development staff will help you understand the business operations as well as support services towards a successful Generika venture.